Skip to content
healthcare.dev
Get a free key

Cyclobenzaprine Hydrochloride

NDC 0093-1921, Cyclobenzaprine Hydrochloride, capsule, extended release, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-1921
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021777
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-1921 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYCLOBENZAPRINE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
0093-1921-060009319210660 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-1921-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ca74d27a-f7c6-462d-a913-1cfa061bd8f3

  • NADAC price for package 00093192106

    GET /v1/drugs/nadac/00093192106

Use it

Look up 0093-1921 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-1921 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-1921. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.